Physician profile
Jonathan Lundy
NPI 1841344678
$2,560.82
in general payments reported to CMS, 2019-2025
15 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $165 · 2021: $149 · 2023: $173 · 2024: $538 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,097.49 | 2019-2025 | |
| Ossur Americas, INC. | $287.34 | 2025 | |
| Acumed LLC | $200.94 | 2019-2020 | |
| Tela Bio, INC. | $187.07 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bioventus LLC | $149.32 | 2021 | |
| Skeletal Dynamics INC | $147.93 | 2024 | Ijs, Geminus, Align |
| Argentum Medical | $101.01 | 2023 | |
| Avita Medical Americas, LLC | $81.39 | 2024 | |
| Kerecis Limited | $72.44 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mimedx Group, INC. | $58.51 | 2024 | |
| Medtronic, INC. | $47.09 | 2024 | Signia |
| Orthofix Medical, INC. | $39.02 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $35.26 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Intuitive Surgical, INC. | $29.97 | 2019 | |
| Alafair Biosciences, INC. | $26.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lundy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.